nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—CYP3A4—Ticagrelor—coronary artery disease	0.0451	0.0901	CbGbCtD
Cevimeline—CYP3A4—Fenofibrate—coronary artery disease	0.0402	0.0803	CbGbCtD
Cevimeline—CYP2D6—Niacin—coronary artery disease	0.0332	0.0664	CbGbCtD
Cevimeline—CYP3A4—Gemfibrozil—coronary artery disease	0.0321	0.0642	CbGbCtD
Cevimeline—CYP2D6—Timolol—coronary artery disease	0.0309	0.0617	CbGbCtD
Cevimeline—CYP3A4—Clopidogrel—coronary artery disease	0.0278	0.0557	CbGbCtD
Cevimeline—CYP2D6—Captopril—coronary artery disease	0.0272	0.0543	CbGbCtD
Cevimeline—CYP2D6—Simvastatin—coronary artery disease	0.0262	0.0525	CbGbCtD
Cevimeline—CYP3A4—Eplerenone—coronary artery disease	0.0259	0.0518	CbGbCtD
Cevimeline—CYP2D6—Lovastatin—coronary artery disease	0.0257	0.0513	CbGbCtD
Cevimeline—CYP2D6—Pravastatin—coronary artery disease	0.0257	0.0513	CbGbCtD
Cevimeline—CYP2D6—Atorvastatin—coronary artery disease	0.0234	0.0468	CbGbCtD
Cevimeline—CYP3A4—Enalapril—coronary artery disease	0.0231	0.0461	CbGbCtD
Cevimeline—CYP3A4—Ezetimibe—coronary artery disease	0.0179	0.0359	CbGbCtD
Cevimeline—CYP3A4—Rosuvastatin—coronary artery disease	0.0179	0.0359	CbGbCtD
Cevimeline—CYP3A4—Simvastatin—coronary artery disease	0.0167	0.0334	CbGbCtD
Cevimeline—CYP3A4—Pravastatin—coronary artery disease	0.0163	0.0326	CbGbCtD
Cevimeline—CYP3A4—Lovastatin—coronary artery disease	0.0163	0.0326	CbGbCtD
Cevimeline—CYP3A4—Atorvastatin—coronary artery disease	0.0149	0.0297	CbGbCtD
Cevimeline—CYP3A4—Losartan—coronary artery disease	0.0136	0.0272	CbGbCtD
Cevimeline—Body temperature increased—Captopril—coronary artery disease	6.3e-05	0.000167	CcSEcCtD
Cevimeline—Dizziness—Simvastatin—coronary artery disease	6.29e-05	0.000167	CcSEcCtD
Cevimeline—Rash—Ezetimibe—coronary artery disease	6.29e-05	0.000167	CcSEcCtD
Cevimeline—Dermatitis—Ezetimibe—coronary artery disease	6.28e-05	0.000167	CcSEcCtD
Cevimeline—Confusional state—Ramipril—coronary artery disease	6.28e-05	0.000167	CcSEcCtD
Cevimeline—Discomfort—Timolol—coronary artery disease	6.27e-05	0.000167	CcSEcCtD
Cevimeline—Asthenia—Niacin—coronary artery disease	6.26e-05	0.000166	CcSEcCtD
Cevimeline—Fatigue—Losartan—coronary artery disease	6.26e-05	0.000166	CcSEcCtD
Cevimeline—Headache—Ezetimibe—coronary artery disease	6.25e-05	0.000166	CcSEcCtD
Cevimeline—Malaise—Lisinopril—coronary artery disease	6.24e-05	0.000166	CcSEcCtD
Cevimeline—Oedema—Ramipril—coronary artery disease	6.23e-05	0.000165	CcSEcCtD
Cevimeline—Vertigo—Lisinopril—coronary artery disease	6.22e-05	0.000165	CcSEcCtD
Cevimeline—Pain—Losartan—coronary artery disease	6.21e-05	0.000165	CcSEcCtD
Cevimeline—Constipation—Losartan—coronary artery disease	6.21e-05	0.000165	CcSEcCtD
Cevimeline—Syncope—Lisinopril—coronary artery disease	6.21e-05	0.000165	CcSEcCtD
Cevimeline—Vomiting—Eplerenone—coronary artery disease	6.21e-05	0.000165	CcSEcCtD
Cevimeline—Feeling abnormal—Furosemide—coronary artery disease	6.2e-05	0.000165	CcSEcCtD
Cevimeline—Leukopenia—Lisinopril—coronary artery disease	6.19e-05	0.000165	CcSEcCtD
Cevimeline—Nausea—Fenofibrate—coronary artery disease	6.18e-05	0.000164	CcSEcCtD
Cevimeline—Pruritus—Niacin—coronary artery disease	6.18e-05	0.000164	CcSEcCtD
Cevimeline—Asthenia—Pravastatin—coronary artery disease	6.17e-05	0.000164	CcSEcCtD
Cevimeline—Gastrointestinal pain—Furosemide—coronary artery disease	6.16e-05	0.000163	CcSEcCtD
Cevimeline—Rash—Eplerenone—coronary artery disease	6.15e-05	0.000163	CcSEcCtD
Cevimeline—Urticaria—Perindopril—coronary artery disease	6.15e-05	0.000163	CcSEcCtD
Cevimeline—Hypersensitivity—Trandolapril—coronary artery disease	6.15e-05	0.000163	CcSEcCtD
Cevimeline—Dermatitis—Eplerenone—coronary artery disease	6.15e-05	0.000163	CcSEcCtD
Cevimeline—Diarrhoea—Valsartan—coronary artery disease	6.14e-05	0.000163	CcSEcCtD
Cevimeline—Confusional state—Timolol—coronary artery disease	6.14e-05	0.000163	CcSEcCtD
Cevimeline—Shock—Ramipril—coronary artery disease	6.13e-05	0.000163	CcSEcCtD
Cevimeline—Hypersensitivity—Enalapril—coronary artery disease	6.13e-05	0.000163	CcSEcCtD
Cevimeline—Abdominal pain—Perindopril—coronary artery disease	6.12e-05	0.000163	CcSEcCtD
Cevimeline—Body temperature increased—Perindopril—coronary artery disease	6.12e-05	0.000163	CcSEcCtD
Cevimeline—Palpitations—Lisinopril—coronary artery disease	6.12e-05	0.000162	CcSEcCtD
Cevimeline—Diarrhoea—Olmesartan—coronary artery disease	6.11e-05	0.000162	CcSEcCtD
Cevimeline—Headache—Eplerenone—coronary artery disease	6.11e-05	0.000162	CcSEcCtD
Cevimeline—Nervous system disorder—Ramipril—coronary artery disease	6.11e-05	0.000162	CcSEcCtD
Cevimeline—Thrombocytopenia—Ramipril—coronary artery disease	6.1e-05	0.000162	CcSEcCtD
Cevimeline—Oedema—Timolol—coronary artery disease	6.09e-05	0.000162	CcSEcCtD
Cevimeline—Pruritus—Pravastatin—coronary artery disease	6.08e-05	0.000162	CcSEcCtD
Cevimeline—Loss of consciousness—Lisinopril—coronary artery disease	6.08e-05	0.000162	CcSEcCtD
Cevimeline—Nausea—Clopidogrel—coronary artery disease	6.08e-05	0.000161	CcSEcCtD
Cevimeline—Tachycardia—Ramipril—coronary artery disease	6.08e-05	0.000161	CcSEcCtD
Cevimeline—Skin disorder—Ramipril—coronary artery disease	6.05e-05	0.000161	CcSEcCtD
Cevimeline—Infection—Timolol—coronary artery disease	6.05e-05	0.000161	CcSEcCtD
Cevimeline—Vomiting—Simvastatin—coronary artery disease	6.05e-05	0.000161	CcSEcCtD
Cevimeline—Hypersensitivity—Telmisartan—coronary artery disease	6.04e-05	0.00016	CcSEcCtD
Cevimeline—Cough—Lisinopril—coronary artery disease	6.04e-05	0.00016	CcSEcCtD
Cevimeline—Nausea—Lovastatin—coronary artery disease	6.04e-05	0.00016	CcSEcCtD
Cevimeline—Hyperhidrosis—Ramipril—coronary artery disease	6.02e-05	0.00016	CcSEcCtD
Cevimeline—Rash—Simvastatin—coronary artery disease	6e-05	0.000159	CcSEcCtD
Cevimeline—Dermatitis—Simvastatin—coronary artery disease	5.99e-05	0.000159	CcSEcCtD
Cevimeline—Asthenia—Trandolapril—coronary artery disease	5.99e-05	0.000159	CcSEcCtD
Cevimeline—Shock—Timolol—coronary artery disease	5.99e-05	0.000159	CcSEcCtD
Cevimeline—Feeling abnormal—Losartan—coronary artery disease	5.98e-05	0.000159	CcSEcCtD
Cevimeline—Urticaria—Furosemide—coronary artery disease	5.98e-05	0.000159	CcSEcCtD
Cevimeline—Diarrhoea—Niacin—coronary artery disease	5.97e-05	0.000159	CcSEcCtD
Cevimeline—Nervous system disorder—Timolol—coronary artery disease	5.97e-05	0.000159	CcSEcCtD
Cevimeline—Asthenia—Enalapril—coronary artery disease	5.97e-05	0.000158	CcSEcCtD
Cevimeline—Headache—Simvastatin—coronary artery disease	5.96e-05	0.000158	CcSEcCtD
Cevimeline—Abdominal pain—Furosemide—coronary artery disease	5.95e-05	0.000158	CcSEcCtD
Cevimeline—Body temperature increased—Furosemide—coronary artery disease	5.95e-05	0.000158	CcSEcCtD
Cevimeline—Gastrointestinal pain—Losartan—coronary artery disease	5.94e-05	0.000158	CcSEcCtD
Cevimeline—Dizziness—Valsartan—coronary artery disease	5.94e-05	0.000158	CcSEcCtD
Cevimeline—Anorexia—Ramipril—coronary artery disease	5.94e-05	0.000158	CcSEcCtD
Cevimeline—Nausea—Ezetimibe—coronary artery disease	5.92e-05	0.000157	CcSEcCtD
Cevimeline—Skin disorder—Timolol—coronary artery disease	5.91e-05	0.000157	CcSEcCtD
Cevimeline—Dizziness—Olmesartan—coronary artery disease	5.91e-05	0.000157	CcSEcCtD
Cevimeline—Pruritus—Trandolapril—coronary artery disease	5.91e-05	0.000157	CcSEcCtD
Cevimeline—Arthralgia—Lisinopril—coronary artery disease	5.89e-05	0.000156	CcSEcCtD
Cevimeline—Chest pain—Lisinopril—coronary artery disease	5.89e-05	0.000156	CcSEcCtD
Cevimeline—Myalgia—Lisinopril—coronary artery disease	5.89e-05	0.000156	CcSEcCtD
Cevimeline—Hyperhidrosis—Timolol—coronary artery disease	5.89e-05	0.000156	CcSEcCtD
Cevimeline—Asthenia—Telmisartan—coronary artery disease	5.88e-05	0.000156	CcSEcCtD
Cevimeline—Pruritus—Enalapril—coronary artery disease	5.88e-05	0.000156	CcSEcCtD
Cevimeline—Diarrhoea—Pravastatin—coronary artery disease	5.88e-05	0.000156	CcSEcCtD
Cevimeline—Anxiety—Lisinopril—coronary artery disease	5.87e-05	0.000156	CcSEcCtD
Cevimeline—Discomfort—Lisinopril—coronary artery disease	5.82e-05	0.000155	CcSEcCtD
Cevimeline—Hypotension—Ramipril—coronary artery disease	5.82e-05	0.000155	CcSEcCtD
Cevimeline—Anorexia—Timolol—coronary artery disease	5.8e-05	0.000154	CcSEcCtD
Cevimeline—Pruritus—Telmisartan—coronary artery disease	5.8e-05	0.000154	CcSEcCtD
Cevimeline—Nausea—Eplerenone—coronary artery disease	5.8e-05	0.000154	CcSEcCtD
Cevimeline—Dizziness—Niacin—coronary artery disease	5.77e-05	0.000153	CcSEcCtD
Cevimeline—Urticaria—Losartan—coronary artery disease	5.77e-05	0.000153	CcSEcCtD
Cevimeline—Abdominal pain—Losartan—coronary artery disease	5.74e-05	0.000152	CcSEcCtD
Cevimeline—Body temperature increased—Losartan—coronary artery disease	5.74e-05	0.000152	CcSEcCtD
Cevimeline—Asthenia—Captopril—coronary artery disease	5.72e-05	0.000152	CcSEcCtD
Cevimeline—Diarrhoea—Trandolapril—coronary artery disease	5.71e-05	0.000152	CcSEcCtD
Cevimeline—Vomiting—Valsartan—coronary artery disease	5.71e-05	0.000152	CcSEcCtD
Cevimeline—Confusional state—Lisinopril—coronary artery disease	5.69e-05	0.000151	CcSEcCtD
Cevimeline—Diarrhoea—Enalapril—coronary artery disease	5.69e-05	0.000151	CcSEcCtD
Cevimeline—Hypotension—Timolol—coronary artery disease	5.69e-05	0.000151	CcSEcCtD
Cevimeline—Dizziness—Pravastatin—coronary artery disease	5.68e-05	0.000151	CcSEcCtD
Cevimeline—Vomiting—Olmesartan—coronary artery disease	5.68e-05	0.000151	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Ramipril—coronary artery disease	5.67e-05	0.000151	CcSEcCtD
Cevimeline—Rash—Valsartan—coronary artery disease	5.66e-05	0.00015	CcSEcCtD
Cevimeline—Dermatitis—Valsartan—coronary artery disease	5.66e-05	0.00015	CcSEcCtD
Cevimeline—Nausea—Simvastatin—coronary artery disease	5.65e-05	0.00015	CcSEcCtD
Cevimeline—Oedema—Lisinopril—coronary artery disease	5.65e-05	0.00015	CcSEcCtD
Cevimeline—Pruritus—Captopril—coronary artery disease	5.64e-05	0.00015	CcSEcCtD
Cevimeline—Rash—Olmesartan—coronary artery disease	5.63e-05	0.00015	CcSEcCtD
Cevimeline—Insomnia—Ramipril—coronary artery disease	5.63e-05	0.00015	CcSEcCtD
Cevimeline—Dermatitis—Olmesartan—coronary artery disease	5.63e-05	0.00015	CcSEcCtD
Cevimeline—Headache—Valsartan—coronary artery disease	5.63e-05	0.000149	CcSEcCtD
Cevimeline—Diarrhoea—Telmisartan—coronary artery disease	5.61e-05	0.000149	CcSEcCtD
Cevimeline—Infection—Lisinopril—coronary artery disease	5.61e-05	0.000149	CcSEcCtD
Cevimeline—Headache—Olmesartan—coronary artery disease	5.6e-05	0.000149	CcSEcCtD
Cevimeline—Paraesthesia—Ramipril—coronary artery disease	5.59e-05	0.000149	CcSEcCtD
Cevimeline—Shock—Lisinopril—coronary artery disease	5.56e-05	0.000148	CcSEcCtD
Cevimeline—Asthenia—Perindopril—coronary artery disease	5.56e-05	0.000148	CcSEcCtD
Cevimeline—Dyspnoea—Ramipril—coronary artery disease	5.55e-05	0.000147	CcSEcCtD
Cevimeline—Vomiting—Niacin—coronary artery disease	5.55e-05	0.000147	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Timolol—coronary artery disease	5.55e-05	0.000147	CcSEcCtD
Cevimeline—Hypersensitivity—Furosemide—coronary artery disease	5.55e-05	0.000147	CcSEcCtD
Cevimeline—Somnolence—Ramipril—coronary artery disease	5.54e-05	0.000147	CcSEcCtD
Cevimeline—Thrombocytopenia—Lisinopril—coronary artery disease	5.53e-05	0.000147	CcSEcCtD
Cevimeline—Dizziness—Trandolapril—coronary artery disease	5.52e-05	0.000147	CcSEcCtD
Cevimeline—Tachycardia—Lisinopril—coronary artery disease	5.51e-05	0.000146	CcSEcCtD
Cevimeline—Insomnia—Timolol—coronary artery disease	5.51e-05	0.000146	CcSEcCtD
Cevimeline—Rash—Niacin—coronary artery disease	5.51e-05	0.000146	CcSEcCtD
Cevimeline—Dermatitis—Niacin—coronary artery disease	5.5e-05	0.000146	CcSEcCtD
Cevimeline—Dizziness—Enalapril—coronary artery disease	5.5e-05	0.000146	CcSEcCtD
Cevimeline—Skin disorder—Lisinopril—coronary artery disease	5.49e-05	0.000146	CcSEcCtD
Cevimeline—Dyspepsia—Ramipril—coronary artery disease	5.48e-05	0.000146	CcSEcCtD
Cevimeline—Pruritus—Perindopril—coronary artery disease	5.48e-05	0.000146	CcSEcCtD
Cevimeline—Headache—Niacin—coronary artery disease	5.47e-05	0.000145	CcSEcCtD
Cevimeline—Paraesthesia—Timolol—coronary artery disease	5.47e-05	0.000145	CcSEcCtD
Cevimeline—Vomiting—Pravastatin—coronary artery disease	5.47e-05	0.000145	CcSEcCtD
Cevimeline—Hyperhidrosis—Lisinopril—coronary artery disease	5.46e-05	0.000145	CcSEcCtD
Cevimeline—Diarrhoea—Captopril—coronary artery disease	5.46e-05	0.000145	CcSEcCtD
Cevimeline—Dyspnoea—Timolol—coronary artery disease	5.43e-05	0.000144	CcSEcCtD
Cevimeline—Dizziness—Telmisartan—coronary artery disease	5.42e-05	0.000144	CcSEcCtD
Cevimeline—Rash—Pravastatin—coronary artery disease	5.42e-05	0.000144	CcSEcCtD
Cevimeline—Dermatitis—Pravastatin—coronary artery disease	5.42e-05	0.000144	CcSEcCtD
Cevimeline—Decreased appetite—Ramipril—coronary artery disease	5.41e-05	0.000144	CcSEcCtD
Cevimeline—Somnolence—Timolol—coronary artery disease	5.41e-05	0.000144	CcSEcCtD
Cevimeline—Asthenia—Furosemide—coronary artery disease	5.4e-05	0.000143	CcSEcCtD
Cevimeline—Headache—Pravastatin—coronary artery disease	5.39e-05	0.000143	CcSEcCtD
Cevimeline—Anorexia—Lisinopril—coronary artery disease	5.38e-05	0.000143	CcSEcCtD
Cevimeline—Fatigue—Ramipril—coronary artery disease	5.37e-05	0.000143	CcSEcCtD
Cevimeline—Dyspepsia—Timolol—coronary artery disease	5.36e-05	0.000142	CcSEcCtD
Cevimeline—Hypersensitivity—Losartan—coronary artery disease	5.35e-05	0.000142	CcSEcCtD
Cevimeline—Nausea—Valsartan—coronary artery disease	5.33e-05	0.000142	CcSEcCtD
Cevimeline—Pruritus—Furosemide—coronary artery disease	5.33e-05	0.000141	CcSEcCtD
Cevimeline—Constipation—Ramipril—coronary artery disease	5.33e-05	0.000141	CcSEcCtD
Cevimeline—Nausea—Olmesartan—coronary artery disease	5.31e-05	0.000141	CcSEcCtD
Cevimeline—Vomiting—Trandolapril—coronary artery disease	5.31e-05	0.000141	CcSEcCtD
Cevimeline—Diarrhoea—Perindopril—coronary artery disease	5.3e-05	0.000141	CcSEcCtD
Cevimeline—Decreased appetite—Timolol—coronary artery disease	5.29e-05	0.000141	CcSEcCtD
Cevimeline—Vomiting—Enalapril—coronary artery disease	5.29e-05	0.00014	CcSEcCtD
Cevimeline—Hypotension—Lisinopril—coronary artery disease	5.28e-05	0.00014	CcSEcCtD
Cevimeline—Dizziness—Captopril—coronary artery disease	5.27e-05	0.00014	CcSEcCtD
Cevimeline—Rash—Trandolapril—coronary artery disease	5.26e-05	0.00014	CcSEcCtD
Cevimeline—Dermatitis—Trandolapril—coronary artery disease	5.26e-05	0.00014	CcSEcCtD
Cevimeline—Fatigue—Timolol—coronary artery disease	5.25e-05	0.000139	CcSEcCtD
Cevimeline—Rash—Enalapril—coronary artery disease	5.24e-05	0.000139	CcSEcCtD
Cevimeline—Dermatitis—Enalapril—coronary artery disease	5.24e-05	0.000139	CcSEcCtD
Cevimeline—Headache—Trandolapril—coronary artery disease	5.23e-05	0.000139	CcSEcCtD
Cevimeline—Vomiting—Telmisartan—coronary artery disease	5.21e-05	0.000139	CcSEcCtD
Cevimeline—Asthenia—Losartan—coronary artery disease	5.21e-05	0.000138	CcSEcCtD
Cevimeline—Headache—Enalapril—coronary artery disease	5.21e-05	0.000138	CcSEcCtD
Cevimeline—Pain—Timolol—coronary artery disease	5.21e-05	0.000138	CcSEcCtD
Cevimeline—Nausea—Niacin—coronary artery disease	5.19e-05	0.000138	CcSEcCtD
Cevimeline—Rash—Telmisartan—coronary artery disease	5.17e-05	0.000137	CcSEcCtD
Cevimeline—Dermatitis—Telmisartan—coronary artery disease	5.17e-05	0.000137	CcSEcCtD
Cevimeline—Diarrhoea—Furosemide—coronary artery disease	5.15e-05	0.000137	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Lisinopril—coronary artery disease	5.15e-05	0.000137	CcSEcCtD
Cevimeline—Pruritus—Losartan—coronary artery disease	5.14e-05	0.000136	CcSEcCtD
Cevimeline—Headache—Telmisartan—coronary artery disease	5.14e-05	0.000136	CcSEcCtD
Cevimeline—Feeling abnormal—Ramipril—coronary artery disease	5.13e-05	0.000136	CcSEcCtD
Cevimeline—Dizziness—Perindopril—coronary artery disease	5.12e-05	0.000136	CcSEcCtD
Cevimeline—Insomnia—Lisinopril—coronary artery disease	5.11e-05	0.000136	CcSEcCtD
Cevimeline—Nausea—Pravastatin—coronary artery disease	5.11e-05	0.000136	CcSEcCtD
Cevimeline—Gastrointestinal pain—Ramipril—coronary artery disease	5.09e-05	0.000135	CcSEcCtD
Cevimeline—Paraesthesia—Lisinopril—coronary artery disease	5.07e-05	0.000135	CcSEcCtD
Cevimeline—Vomiting—Captopril—coronary artery disease	5.07e-05	0.000135	CcSEcCtD
Cevimeline—Dyspnoea—Lisinopril—coronary artery disease	5.04e-05	0.000134	CcSEcCtD
Cevimeline—Rash—Captopril—coronary artery disease	5.03e-05	0.000134	CcSEcCtD
Cevimeline—Dermatitis—Captopril—coronary artery disease	5.02e-05	0.000133	CcSEcCtD
Cevimeline—Somnolence—Lisinopril—coronary artery disease	5.02e-05	0.000133	CcSEcCtD
Cevimeline—Feeling abnormal—Timolol—coronary artery disease	5.02e-05	0.000133	CcSEcCtD
Cevimeline—Headache—Captopril—coronary artery disease	5e-05	0.000133	CcSEcCtD
Cevimeline—Gastrointestinal pain—Timolol—coronary artery disease	4.98e-05	0.000132	CcSEcCtD
Cevimeline—Dizziness—Furosemide—coronary artery disease	4.98e-05	0.000132	CcSEcCtD
Cevimeline—Dyspepsia—Lisinopril—coronary artery disease	4.97e-05	0.000132	CcSEcCtD
Cevimeline—Diarrhoea—Losartan—coronary artery disease	4.97e-05	0.000132	CcSEcCtD
Cevimeline—Nausea—Trandolapril—coronary artery disease	4.96e-05	0.000132	CcSEcCtD
Cevimeline—Urticaria—Ramipril—coronary artery disease	4.95e-05	0.000131	CcSEcCtD
Cevimeline—Nausea—Enalapril—coronary artery disease	4.94e-05	0.000131	CcSEcCtD
Cevimeline—Vomiting—Perindopril—coronary artery disease	4.92e-05	0.000131	CcSEcCtD
Cevimeline—Abdominal pain—Ramipril—coronary artery disease	4.92e-05	0.000131	CcSEcCtD
Cevimeline—Body temperature increased—Ramipril—coronary artery disease	4.92e-05	0.000131	CcSEcCtD
Cevimeline—Decreased appetite—Lisinopril—coronary artery disease	4.91e-05	0.00013	CcSEcCtD
Cevimeline—Rash—Perindopril—coronary artery disease	4.88e-05	0.00013	CcSEcCtD
Cevimeline—Dermatitis—Perindopril—coronary artery disease	4.88e-05	0.00013	CcSEcCtD
Cevimeline—Nausea—Telmisartan—coronary artery disease	4.87e-05	0.000129	CcSEcCtD
Cevimeline—Fatigue—Lisinopril—coronary artery disease	4.87e-05	0.000129	CcSEcCtD
Cevimeline—Headache—Perindopril—coronary artery disease	4.85e-05	0.000129	CcSEcCtD
Cevimeline—Urticaria—Timolol—coronary artery disease	4.84e-05	0.000128	CcSEcCtD
Cevimeline—Constipation—Lisinopril—coronary artery disease	4.83e-05	0.000128	CcSEcCtD
Cevimeline—Pain—Lisinopril—coronary artery disease	4.83e-05	0.000128	CcSEcCtD
Cevimeline—Body temperature increased—Timolol—coronary artery disease	4.81e-05	0.000128	CcSEcCtD
Cevimeline—Abdominal pain—Timolol—coronary artery disease	4.81e-05	0.000128	CcSEcCtD
Cevimeline—Dizziness—Losartan—coronary artery disease	4.8e-05	0.000128	CcSEcCtD
Cevimeline—Vomiting—Furosemide—coronary artery disease	4.79e-05	0.000127	CcSEcCtD
Cevimeline—Rash—Furosemide—coronary artery disease	4.75e-05	0.000126	CcSEcCtD
Cevimeline—Dermatitis—Furosemide—coronary artery disease	4.74e-05	0.000126	CcSEcCtD
Cevimeline—Nausea—Captopril—coronary artery disease	4.74e-05	0.000126	CcSEcCtD
Cevimeline—Headache—Furosemide—coronary artery disease	4.72e-05	0.000125	CcSEcCtD
Cevimeline—Feeling abnormal—Lisinopril—coronary artery disease	4.65e-05	0.000124	CcSEcCtD
Cevimeline—Gastrointestinal pain—Lisinopril—coronary artery disease	4.62e-05	0.000123	CcSEcCtD
Cevimeline—Vomiting—Losartan—coronary artery disease	4.62e-05	0.000123	CcSEcCtD
Cevimeline—Nausea—Perindopril—coronary artery disease	4.6e-05	0.000122	CcSEcCtD
Cevimeline—Hypersensitivity—Ramipril—coronary artery disease	4.59e-05	0.000122	CcSEcCtD
Cevimeline—Rash—Losartan—coronary artery disease	4.58e-05	0.000122	CcSEcCtD
Cevimeline—Dermatitis—Losartan—coronary artery disease	4.57e-05	0.000122	CcSEcCtD
Cevimeline—Headache—Losartan—coronary artery disease	4.55e-05	0.000121	CcSEcCtD
Cevimeline—Urticaria—Lisinopril—coronary artery disease	4.49e-05	0.000119	CcSEcCtD
Cevimeline—Hypersensitivity—Timolol—coronary artery disease	4.49e-05	0.000119	CcSEcCtD
Cevimeline—Nausea—Furosemide—coronary artery disease	4.47e-05	0.000119	CcSEcCtD
Cevimeline—Asthenia—Ramipril—coronary artery disease	4.47e-05	0.000119	CcSEcCtD
Cevimeline—Abdominal pain—Lisinopril—coronary artery disease	4.46e-05	0.000119	CcSEcCtD
Cevimeline—Body temperature increased—Lisinopril—coronary artery disease	4.46e-05	0.000119	CcSEcCtD
Cevimeline—Pruritus—Ramipril—coronary artery disease	4.41e-05	0.000117	CcSEcCtD
Cevimeline—Asthenia—Timolol—coronary artery disease	4.37e-05	0.000116	CcSEcCtD
Cevimeline—Nausea—Losartan—coronary artery disease	4.31e-05	0.000115	CcSEcCtD
Cevimeline—Pruritus—Timolol—coronary artery disease	4.31e-05	0.000114	CcSEcCtD
Cevimeline—Diarrhoea—Ramipril—coronary artery disease	4.26e-05	0.000113	CcSEcCtD
Cevimeline—Diarrhoea—Timolol—coronary artery disease	4.17e-05	0.000111	CcSEcCtD
Cevimeline—Hypersensitivity—Lisinopril—coronary artery disease	4.16e-05	0.000111	CcSEcCtD
Cevimeline—Dizziness—Ramipril—coronary artery disease	4.12e-05	0.000109	CcSEcCtD
Cevimeline—Asthenia—Lisinopril—coronary artery disease	4.05e-05	0.000108	CcSEcCtD
Cevimeline—Dizziness—Timolol—coronary artery disease	4.03e-05	0.000107	CcSEcCtD
Cevimeline—Pruritus—Lisinopril—coronary artery disease	4e-05	0.000106	CcSEcCtD
Cevimeline—Vomiting—Ramipril—coronary artery disease	3.96e-05	0.000105	CcSEcCtD
Cevimeline—Rash—Ramipril—coronary artery disease	3.93e-05	0.000104	CcSEcCtD
Cevimeline—Dermatitis—Ramipril—coronary artery disease	3.92e-05	0.000104	CcSEcCtD
Cevimeline—Headache—Ramipril—coronary artery disease	3.9e-05	0.000104	CcSEcCtD
Cevimeline—Vomiting—Timolol—coronary artery disease	3.87e-05	0.000103	CcSEcCtD
Cevimeline—Diarrhoea—Lisinopril—coronary artery disease	3.86e-05	0.000103	CcSEcCtD
Cevimeline—Rash—Timolol—coronary artery disease	3.84e-05	0.000102	CcSEcCtD
Cevimeline—Dermatitis—Timolol—coronary artery disease	3.84e-05	0.000102	CcSEcCtD
Cevimeline—Headache—Timolol—coronary artery disease	3.81e-05	0.000101	CcSEcCtD
Cevimeline—Dizziness—Lisinopril—coronary artery disease	3.73e-05	9.92e-05	CcSEcCtD
Cevimeline—Nausea—Ramipril—coronary artery disease	3.7e-05	9.82e-05	CcSEcCtD
Cevimeline—Nausea—Timolol—coronary artery disease	3.62e-05	9.6e-05	CcSEcCtD
Cevimeline—Vomiting—Lisinopril—coronary artery disease	3.59e-05	9.54e-05	CcSEcCtD
Cevimeline—Rash—Lisinopril—coronary artery disease	3.56e-05	9.46e-05	CcSEcCtD
Cevimeline—Dermatitis—Lisinopril—coronary artery disease	3.56e-05	9.45e-05	CcSEcCtD
Cevimeline—Headache—Lisinopril—coronary artery disease	3.54e-05	9.4e-05	CcSEcCtD
Cevimeline—Nausea—Lisinopril—coronary artery disease	3.35e-05	8.91e-05	CcSEcCtD
Cevimeline—CYP2D6—Metabolism—HBA1—coronary artery disease	1.12e-05	9.05e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	1.12e-05	9.05e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CYP2C19—coronary artery disease	1.12e-05	9.05e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GPX1—coronary artery disease	1.11e-05	9.01e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APOC3—coronary artery disease	1.11e-05	8.99e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—LDLR—coronary artery disease	1.1e-05	8.94e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ADRB2—coronary artery disease	1.1e-05	8.93e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ADRB2—coronary artery disease	1.1e-05	8.91e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—SLC9A1—coronary artery disease	1.09e-05	8.83e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GSTT1—coronary artery disease	1.09e-05	8.83e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PRKCE—coronary artery disease	1.09e-05	8.82e-05	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—JAK2—coronary artery disease	1.09e-05	8.81e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SOCS1—coronary artery disease	1.09e-05	8.8e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PRKCE—coronary artery disease	1.09e-05	8.79e-05	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—JAK2—coronary artery disease	1.08e-05	8.78e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—S100B—coronary artery disease	1.08e-05	8.78e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CD36—coronary artery disease	1.08e-05	8.77e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SOCS1—coronary artery disease	1.08e-05	8.77e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PDHA1—coronary artery disease	1.08e-05	8.76e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GCLM—coronary artery disease	1.08e-05	8.76e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—S100B—coronary artery disease	1.08e-05	8.75e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CETP—coronary artery disease	1.08e-05	8.73e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GCLC—coronary artery disease	1.08e-05	8.73e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SOCS3—coronary artery disease	1.07e-05	8.69e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PPP2CA—coronary artery disease	1.07e-05	8.66e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SOCS3—coronary artery disease	1.07e-05	8.66e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—SDC1—coronary artery disease	1.07e-05	8.63e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TGFBR2—coronary artery disease	1.06e-05	8.59e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—KITLG—coronary artery disease	1.06e-05	8.59e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—KITLG—coronary artery disease	1.06e-05	8.56e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TGFBR2—coronary artery disease	1.06e-05	8.56e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP11B2—coronary artery disease	1.05e-05	8.48e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—TXNRD1—coronary artery disease	1.05e-05	8.48e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MMP3—coronary artery disease	1.04e-05	8.39e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—STAT5A—coronary artery disease	1.04e-05	8.39e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MMP3—coronary artery disease	1.03e-05	8.37e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—STAT5A—coronary artery disease	1.03e-05	8.37e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SLC22A3—coronary artery disease	1.03e-05	8.35e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—MTHFR—coronary artery disease	1.03e-05	8.31e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ARNTL—coronary artery disease	1.02e-05	8.23e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HADH—coronary artery disease	1.02e-05	8.23e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PSMB5—coronary artery disease	1.01e-05	8.15e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PSMA6—coronary artery disease	1.01e-05	8.15e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APOB—coronary artery disease	1e-05	8.11e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APOB—coronary artery disease	9.99e-06	8.09e-05	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—CXCL8—coronary artery disease	9.93e-06	8.04e-05	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—CXCL8—coronary artery disease	9.9e-06	8.02e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—JAK2—coronary artery disease	9.88e-06	8e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—EDN1—coronary artery disease	9.86e-06	7.98e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—JAK2—coronary artery disease	9.85e-06	7.98e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CTGF—coronary artery disease	9.84e-06	7.97e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—EDN1—coronary artery disease	9.83e-06	7.96e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCL5—coronary artery disease	9.78e-06	7.92e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—AGT—coronary artery disease	9.76e-06	7.9e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCL5—coronary artery disease	9.75e-06	7.9e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GOT2—coronary artery disease	9.75e-06	7.89e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—HMGCR—coronary artery disease	9.75e-06	7.89e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	9.64e-06	7.81e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOA2—coronary artery disease	9.64e-06	7.81e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GPX2—coronary artery disease	9.64e-06	7.81e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CSF2—coronary artery disease	9.64e-06	7.8e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FGF1—coronary artery disease	9.64e-06	7.8e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CSF2—coronary artery disease	9.61e-06	7.78e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FGF1—coronary artery disease	9.61e-06	7.78e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—LPL—coronary artery disease	9.57e-06	7.75e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—APOE—coronary artery disease	9.56e-06	7.74e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—LPL—coronary artery disease	9.53e-06	7.72e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SULT1A1—coronary artery disease	9.52e-06	7.71e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ABCG5—coronary artery disease	9.52e-06	7.71e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HK1—coronary artery disease	9.52e-06	7.71e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GPX4—coronary artery disease	9.52e-06	7.71e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MEF2C—coronary artery disease	9.48e-06	7.68e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—RPS6KB1—coronary artery disease	9.48e-06	7.68e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MEF2C—coronary artery disease	9.45e-06	7.65e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—RPS6KB1—coronary artery disease	9.45e-06	7.65e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—APOA1—coronary artery disease	9.45e-06	7.65e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HADHA—coronary artery disease	9.41e-06	7.62e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GSTA1—coronary artery disease	9.3e-06	7.53e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ITGB3—coronary artery disease	9.24e-06	7.48e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ITGB3—coronary artery disease	9.21e-06	7.46e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—LPA—coronary artery disease	9.2e-06	7.45e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CXCL8—coronary artery disease	9.02e-06	7.3e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CXCL8—coronary artery disease	8.99e-06	7.28e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PPP2CA—coronary artery disease	8.97e-06	7.27e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PLCB1—coronary artery disease	8.96e-06	7.26e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PPP2CA—coronary artery disease	8.95e-06	7.24e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PLCB3—coronary artery disease	8.91e-06	7.21e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOA5—coronary artery disease	8.82e-06	7.14e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PRKCD—coronary artery disease	8.81e-06	7.14e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PRKCD—coronary artery disease	8.78e-06	7.11e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ABCA1—coronary artery disease	8.69e-06	7.04e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—P4HB—coronary artery disease	8.65e-06	7e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR2A—coronary artery disease	8.62e-06	6.98e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—C3—coronary artery disease	8.61e-06	6.97e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR2A—coronary artery disease	8.6e-06	6.96e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—C3—coronary artery disease	8.58e-06	6.95e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	8.49e-06	6.87e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GOT1—coronary artery disease	8.42e-06	6.81e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GGT1—coronary artery disease	8.42e-06	6.81e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PPARG—coronary artery disease	8.33e-06	6.74e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HIF1A—coronary artery disease	8.21e-06	6.65e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—POMC—coronary artery disease	8.21e-06	6.65e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HIF1A—coronary artery disease	8.19e-06	6.63e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AGT—coronary artery disease	8.18e-06	6.63e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AGT—coronary artery disease	8.16e-06	6.61e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APOE—coronary artery disease	8.02e-06	6.49e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—LEP—coronary artery disease	8.02e-06	6.49e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—VCAN—coronary artery disease	8e-06	6.48e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—LEP—coronary artery disease	7.99e-06	6.47e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APOE—coronary artery disease	7.99e-06	6.47e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALDOA—coronary artery disease	7.94e-06	6.43e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APOA1—coronary artery disease	7.93e-06	6.42e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APOA1—coronary artery disease	7.9e-06	6.4e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—KDR—coronary artery disease	7.86e-06	6.36e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—KDR—coronary artery disease	7.83e-06	6.34e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MAPK14—coronary artery disease	7.8e-06	6.32e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MAPK14—coronary artery disease	7.78e-06	6.3e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—DCN—coronary artery disease	7.71e-06	6.24e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ESR1—coronary artery disease	7.65e-06	6.2e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ESR1—coronary artery disease	7.63e-06	6.18e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—F2—coronary artery disease	7.56e-06	6.12e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FN1—coronary artery disease	7.56e-06	6.12e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GSTP1—coronary artery disease	7.56e-06	6.12e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FN1—coronary artery disease	7.54e-06	6.1e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—F2—coronary artery disease	7.54e-06	6.1e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL6ST—coronary artery disease	7.53e-06	6.1e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL6ST—coronary artery disease	7.51e-06	6.08e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALDH2—coronary artery disease	7.5e-06	6.07e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	7.49e-06	6.06e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ALB—coronary artery disease	7.49e-06	6.06e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NFKBIA—coronary artery disease	7.47e-06	6.05e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—HMOX1—coronary artery disease	7.45e-06	6.04e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NFKBIA—coronary artery disease	7.45e-06	6.03e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CAT—coronary artery disease	7.36e-06	5.96e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—LIPC—coronary artery disease	7.3e-06	5.92e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HBA1—coronary artery disease	7.3e-06	5.92e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP2C19—coronary artery disease	7.3e-06	5.92e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	7.3e-06	5.92e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOC3—coronary artery disease	7.26e-06	5.88e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—KIT—coronary artery disease	7.24e-06	5.86e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—LDLR—coronary artery disease	7.22e-06	5.84e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—KIT—coronary artery disease	7.21e-06	5.84e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—NOS3—coronary artery disease	7.16e-06	5.8e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APOB—coronary artery disease	7.14e-06	5.78e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SLC9A1—coronary artery disease	7.13e-06	5.77e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GSTT1—coronary artery disease	7.13e-06	5.77e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GCLC—coronary artery disease	7.05e-06	5.71e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CETP—coronary artery disease	7.05e-06	5.71e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SDC1—coronary artery disease	6.97e-06	5.64e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GSTM1—coronary artery disease	6.95e-06	5.62e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GSK3B—coronary artery disease	6.94e-06	5.62e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GSK3B—coronary artery disease	6.92e-06	5.61e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—POMC—coronary artery disease	6.89e-06	5.58e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CREB1—coronary artery disease	6.89e-06	5.58e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—POMC—coronary artery disease	6.87e-06	5.56e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CREB1—coronary artery disease	6.87e-06	5.56e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—LPL—coronary artery disease	6.82e-06	5.52e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCL2—coronary artery disease	6.74e-06	5.46e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL6R—coronary artery disease	6.72e-06	5.44e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCL2—coronary artery disease	6.72e-06	5.44e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL6R—coronary artery disease	6.7e-06	5.42e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GPX1—coronary artery disease	6.65e-06	5.39e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IGF1—coronary artery disease	6.63e-06	5.37e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IGF1—coronary artery disease	6.6e-06	5.35e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—MAPK1—coronary artery disease	6.59e-06	5.34e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PSMA6—coronary artery disease	6.58e-06	5.33e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PSMB5—coronary artery disease	6.58e-06	5.33e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—MAPK1—coronary artery disease	6.57e-06	5.32e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PTGS2—coronary artery disease	6.55e-06	5.3e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CD36—coronary artery disease	6.48e-06	5.25e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CTGF—coronary artery disease	6.43e-06	5.21e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PPP2CA—coronary artery disease	6.4e-06	5.18e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GOT2—coronary artery disease	6.37e-06	5.16e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HMGCR—coronary artery disease	6.37e-06	5.16e-05	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	6.3e-06	5.1e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SERPINE1—coronary artery disease	6.29e-06	5.09e-05	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PIK3CA—coronary artery disease	6.28e-06	5.09e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SERPINE1—coronary artery disease	6.27e-06	5.08e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—MTHFR—coronary artery disease	6.14e-06	4.97e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FGF2—coronary artery disease	6.09e-06	4.93e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FGF2—coronary artery disease	6.07e-06	4.92e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NOS3—coronary artery disease	6.01e-06	4.86e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NOS3—coronary artery disease	5.99e-06	4.85e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PLCB1—coronary artery disease	5.86e-06	4.75e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—JAK2—coronary artery disease	5.84e-06	4.73e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—AGT—coronary artery disease	5.83e-06	4.72e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—JAK2—coronary artery disease	5.82e-06	4.71e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	5.72e-06	4.63e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APOE—coronary artery disease	5.72e-06	4.63e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PIK3CA—coronary artery disease	5.7e-06	4.62e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ABCA1—coronary artery disease	5.68e-06	4.6e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APOA1—coronary artery disease	5.65e-06	4.58e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GGT1—coronary artery disease	5.5e-06	4.46e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GOT1—coronary artery disease	5.5e-06	4.46e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	5.33e-06	4.31e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	5.31e-06	4.3e-05	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	5.15e-06	4.17e-05	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	5.13e-06	4.15e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CASP3—coronary artery disease	5.1e-06	4.13e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CASP3—coronary artery disease	5.08e-06	4.12e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—IL6—coronary artery disease	5.07e-06	4.1e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—IL6—coronary artery disease	5.05e-06	4.09e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PPARG—coronary artery disease	4.98e-06	4.03e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCND1—coronary artery disease	4.96e-06	4.02e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCND1—coronary artery disease	4.95e-06	4.01e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GSTP1—coronary artery disease	4.94e-06	4e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—POMC—coronary artery disease	4.91e-06	3.98e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	4.9e-06	3.96e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HMOX1—coronary artery disease	4.87e-06	3.95e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MMP9—coronary artery disease	4.82e-06	3.9e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CAT—coronary artery disease	4.81e-06	3.89e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MMP9—coronary artery disease	4.8e-06	3.89e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	4.67e-06	3.79e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOB—coronary artery disease	4.67e-06	3.78e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	4.66e-06	3.77e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GSTM1—coronary artery disease	4.54e-06	3.68e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ALB—coronary artery disease	4.48e-06	3.62e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—LPL—coronary artery disease	4.46e-06	3.61e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GPX1—coronary artery disease	4.35e-06	3.52e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	4.33e-06	3.5e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	4.31e-06	3.49e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NOS3—coronary artery disease	4.28e-06	3.47e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CD36—coronary artery disease	4.24e-06	3.43e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PPP2CA—coronary artery disease	4.18e-06	3.39e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PIK3CA—coronary artery disease	4.03e-06	3.26e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—MTHFR—coronary artery disease	4.01e-06	3.25e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	3.97e-06	3.22e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	3.96e-06	3.21e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PTGS2—coronary artery disease	3.92e-06	3.17e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	3.9e-06	3.15e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	3.88e-06	3.14e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—AGT—coronary artery disease	3.81e-06	3.09e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOE—coronary artery disease	3.74e-06	3.03e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOA1—coronary artery disease	3.69e-06	2.99e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	3.38e-06	2.74e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	3.37e-06	2.73e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—AKT1—coronary artery disease	3.29e-06	2.67e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PPARG—coronary artery disease	3.25e-06	2.64e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—POMC—coronary artery disease	3.21e-06	2.6e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL6—coronary artery disease	2.99e-06	2.42e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL6—coronary artery disease	2.98e-06	2.42e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALB—coronary artery disease	2.93e-06	2.37e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NOS3—coronary artery disease	2.8e-06	2.27e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AKT1—coronary artery disease	2.76e-06	2.24e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AKT1—coronary artery disease	2.75e-06	2.23e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PTGS2—coronary artery disease	2.56e-06	2.07e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PIK3CA—coronary artery disease	2.41e-06	1.95e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—AKT1—coronary artery disease	1.97e-06	1.59e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.58e-06	1.28e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—AKT1—coronary artery disease	1.29e-06	1.04e-05	CbGpPWpGaD
